GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (NAS:ADXN) » Definitions » Accumulated other comprehensive income (loss)

Addex Therapeutics (Addex Therapeutics) Accumulated other comprehensive income (loss) : $34.48 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Addex Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Addex Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was $34.48 Mil.

Addex Therapeutics's quarterly Accumulated other comprehensive income (loss) declined from Jun. 2023 ($35.61 Mil) to Sep. 2023 ($35.21 Mil) and declined from Sep. 2023 ($35.21 Mil) to Dec. 2023 ($34.48 Mil).

Addex Therapeutics's annual Accumulated other comprehensive income (loss) increased from Dec. 2021 ($26.53 Mil) to Dec. 2022 ($27.66 Mil) and increased from Dec. 2022 ($27.66 Mil) to Dec. 2023 ($34.48 Mil).


Addex Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Addex Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics Accumulated other comprehensive income (loss) Chart

Addex Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.27 16.50 26.53 27.66 34.48

Addex Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.66 28.28 35.61 35.21 34.48

Addex Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Addex Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Addex Therapeutics (Addex Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (NAS:ADXN) » Definitions » Accumulated other comprehensive income (loss)
Traded in Other Exchanges
Address
Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68, Geneva, CHE, 1202
Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Addex Therapeutics (Addex Therapeutics) Headlines

From GuruFocus

Enamine Extend Collaboration With Prominent Swiss Biotech

By Business Wire Business Wire 02-24-2021